Clinical trial
Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease
NCT00123942 · MedImmune LLC, Industry · Terminated
Key facts
| NCT number | NCT00123942 |
|---|---|
| Title | Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease |
| Official title | Phase I Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease |
| Lead sponsor | MedImmune LLC, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoproliferative Disorders |
| Intervention type | Drug |
| Interventions | MEDI-507 |
| Enrollment | 31 |
| Start date | Apr 1, 2004 |
| First posted | Jul 26, 2005 |
| Last update posted | Jun 14, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: